157 related articles for article (PubMed ID: 32228357)
1. Novel Insights Into the Long-Term Immune Health of Diffuse Large B-Cell Lymphoma Survivors.
Morton LM
J Clin Oncol; 2020 May; 38(15):1648-1650. PubMed ID: 32228357
[No Abstract] [Full Text] [Related]
2. Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
Xiao DY; Luo S; O'Brian K; Sanfilippo KM; Ganti A; Riedell P; Lynch RC; Liu W; Kahl BS; Cashen AF; Fehniger TA; Carson KR
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381623
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study.
Lee SF; Vellayappan BA; Wong LC; Chiang CL; Chan SK; Wan EY; Wong IC; Lambert PC; Rachet B; Ng AK; Luque-Fernandez MA
ESMO Open; 2022 Feb; 7(1):100363. PubMed ID: 35026723
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of diffuse large B cell lymphoma of the trigeminal region extending to the Meckel's cave treated by CHASER therapy: case report.
Tanaka T; Kato N; Itoh K; Hasegawa Y
Neurol Med Chir (Tokyo); 2014; 54(8):677-80. PubMed ID: 24305022
[TBL] [Abstract][Full Text] [Related]
5. NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.
Cai Q; Tu M; Xu-Monette ZY; Sun R; Manyam GC; Xu X; Tzankov A; Hsi ED; Møller MB; Medeiros LJ; Ok CY; Young KH
Mod Pathol; 2017 Jun; 30(6):854-876. PubMed ID: 28281555
[TBL] [Abstract][Full Text] [Related]
6. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors.
Berkman AM; Andersen CR; Puthenpura V; Livingston JA; Ahmed S; Cuglievan B; Hildebrandt MAT; Roth ME
Cancer Epidemiol; 2021 Dec; 75():102044. PubMed ID: 34597882
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study.
Juul MB; Jelicic J; Anru PL; Engberg H; Hammershøj Jensen P; Kristensen HB; Baech J; Clausen MR; Gang AO; Munksgaard L; El-Galaly TC; Frederiksen H; Stauffer Larsen T
Leuk Lymphoma; 2022 Sep; 63(9):2074-2083. PubMed ID: 35437098
[TBL] [Abstract][Full Text] [Related]
8. [A case report of unresectable mesenteric malignant lymphoma with long survival].
Nakamura Y; Nagao J; Saida Y; Nakamura Y; Katagiri M; Asai K; Watanabe M; Kusachi S; Sumiyama Y; Takahashi K
Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1238-42. PubMed ID: 15570874
[No Abstract] [Full Text] [Related]
9. Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis.
Derigs P; Bethge WA; Krämer I; Holtick U; von Tresckow B; Ayuk F; Penack O; Vucinic V; von Bonin M; Baldus C; Mougiakakos D; Wulf G; Schnetzke U; Stelljes M; Fante M; Schroers R; Kroeger N; Dreger P;
Transplant Cell Ther; 2023 Dec; 29(12):750-756. PubMed ID: 37709204
[TBL] [Abstract][Full Text] [Related]
10. Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark.
Jakobsen LH; Øvlisen AK; Severinsen MT; Bæch J; Kragholm KH; Glimelius I; Gang AO; Jørgensen JM; Frederiksen H; Poulsen CB; Clausen MR; Pedersen PT; Pedersen RS; Torp-Pedersen C; Eloranta S; El-Galaly TC
Blood Cancer J; 2022 Jan; 12(1):16. PubMed ID: 35087026
[TBL] [Abstract][Full Text] [Related]
11. My treatment approach to patients with diffuse large B-cell lymphoma.
Armitage JO
Mayo Clin Proc; 2012 Feb; 87(2):161-71. PubMed ID: 22305028
[TBL] [Abstract][Full Text] [Related]
12. Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma.
Spriano F; Chung EY; Panini N; Cascione L; Rinaldi A; Erba E; Stathis A; D'Incalci M; Bertoni F; Gatta R
Br J Haematol; 2019 Mar; 184(6):1022-1025. PubMed ID: 29611184
[No Abstract] [Full Text] [Related]
13. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.
Geurts YM; Neppelenbroek SIM; Aleman BMP; Janus CPM; Krol ADG; van Spronsen DJ; Plattel WJ; Roesink JM; Verschueren KMS; Zijlstra JM; Koene HR; Nijziel MR; Schimmel EC; de Jongh E; Ong F; Te Boome LCJ; van Rijn RS; Böhmer LH; Ta BDP; Visser HPJ; Posthuma EFM; Bilgin YM; Muller K; van Kampen D; So-Osman C; Vermaat JSP; de Weijer RJ; Kersten MJ; van Leeuwen FE; Schaapveld M
ESMO Open; 2024 Feb; 9(2):102248. PubMed ID: 38350338
[TBL] [Abstract][Full Text] [Related]
14. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.
Shenkier TN; Voss N; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Klimo P; O'Reilly SE; Sutcliffe S; Connors JM
J Clin Oncol; 2002 Jan; 20(1):197-204. PubMed ID: 11773170
[TBL] [Abstract][Full Text] [Related]
15. [Diffuse Large B cell Lymphoma - Modern Dia-gnostics and Molecularly Targeted Treatment].
Pytlík R; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S64-72. PubMed ID: 26489504
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
17. [The role of radiotherapy in chemoradiation treatment for nodal diffuse large B-cell non-Hodgkin lymphoma].
Vinogradova YN; Iliin NV
Vopr Onkol; 2015; 61(1):96-101. PubMed ID: 26016153
[TBL] [Abstract][Full Text] [Related]
18. Durable Long-Term Response in a Patient With Diffuse Large B-Cell Lymphoma Treated With Nivolumab.
Ginnaram SR; Mason EF; Reddy NM
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e934-e936. PubMed ID: 32778514
[No Abstract] [Full Text] [Related]
19. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†.
Di M; Panagiotou OA; Reagan JL; Niroula R; Olszewski AJ
Leuk Lymphoma; 2020 Dec; 61(14):3360-3368. PubMed ID: 32915087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
